ProMIS Neurosciences Inc. (PMN) Stock Price

12.70 ▼ -0.18 (-1.40%)
Open: 12.78 Vol: 40.12K Day's range: 12.69 - 13.99 Mar 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PMN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 12.97▼ 12.98▼ 13.00▼ 14.26▼ 17.32▼
MA10 13.00▼ 13.17▼ 13.19▼ 15.93▼ 16.83▼
MA20 13.18▼ 13.47▼ 13.96▼ 18.75▼ 12.07▲
MA50 13.83▼ 15.19▼ 16.16▼ 16.43▼ 5.14▲
MA100 14.71▼ 16.92▼ 19.09▼ 11.00▲ 3.16▲
MA200 16.46▼ 19.44▼ 17.78▼ 5.76▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.020▲ 0.048▲ 0.032▲ -1.009▼ -0.092▼
RSI 36.608▼ 31.360▼ 32.034▼ 32.712▼ 54.180▲
STOCH 37.660     11.161▼ 8.768▼ 9.351▼ 51.203    
WILL %R -100.000▼ -100.000▼ -100.000▼ -99.882▼ -70.741    
CCI -154.717▼ -97.878     -84.053     -148.338▼ -20.365    
Latest Filters Detected On PMN
▼ BREAK $PMN Price Breaks 30 Days Low Set Alert
▼ BREAK $PMN Price Breaks 20 Days Low Set Alert
▼ BREAK $PMN Price Breaks 10 Days Low Set Alert
CDL $PMN Doji Star Candlestick Pattern Detected Set Alert
CDL $PMN Doji Candlestick Pattern Detected Set Alert
ProMIS Neurosciences Inc. News
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
Wednesday, March 18, 2026 05:20 AM
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s ...
Wednesday, March 18, 2026 04:03 AM
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announce ...
ProMIS Neurosciences Announces Reverse Stock Split
Monday, November 24, 2025 05:00 AM
Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) ...
PMN historical stock data
date open high low close volume
31/03/26 12.78 13.99 12.69 12.70 40,116
30/03/26 14.675 14.675 12.72 12.88 34,685
27/03/26 14.785 15.20 14.26 14.74 31,663
26/03/26 15.80 15.92 14.132 15.13 31,669
25/03/26 17.44 18.00 15.85 15.85 21,600
24/03/26 17.43 18.715 17.43 17.43 16,394
23/03/26 17.81 18.16 17.595 17.77 7,336
20/03/26 19.0043 19.0043 17.24 17.60 15,172
19/03/26 16.56 18.44 16.04 18.21 37,668
18/03/26 19.83 19.83 17.00 17.00 28,056
Quote Details
52wk Low:0.29
52wk High:27.40
Vol:40.12K
Avg Vol(3m):3.5M
1Y Chng:+1,968.40%
1M Chng:-22.04%
Add to Watch List
More Information
Index US Composite
Market Cap. 115.50M